Literature DB >> 12663813

The barrier-to-autointegration factor is a component of functional human immunodeficiency virus type 1 preintegration complexes.

Chou-Wen Lin1, Alan Engelman.   

Abstract

Retroviral integration in vivo is mediated by preintegration complexes (PICs) derived from infectious virions. In addition to the integrase enzyme and cDNA substrate, PICs contain a variety of viral and host cell proteins. Whereas two different cell proteins, high-mobility group protein A1 (HMGA1) and the barrier-to-autointegration factor (BAF), were identified as integration cofactors based on activities in in vitro PIC assays, only HMGA1 was previously identified as a PIC component. By using antibodies against known viral and cellular PIC components, we demonstrate here functional coimmunoprecipitation of endogenous BAF protein with human immunodeficiency virus type 1 (HIV-1) PICs. Since integrase protein and integration activity were also coimmunoprecipitated by anti-BAF antibodies, we conclude that BAF is a component of HIV-1 PICs. These data are consistent with the model that BAF functions as an integration cofactor in vivo.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12663813      PMCID: PMC152146          DOI: 10.1128/jvi.77.8.5030-5036.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Revised nomenclature for high mobility group (HMG) chromosomal proteins.

Authors:  M Bustin
Journal:  Trends Biochem Sci       Date:  2001-03       Impact factor: 13.807

2.  Barrier-to-autointegration factor (BAF) bridges DNA in a discrete, higher-order nucleoprotein complex.

Authors:  R Zheng; R Ghirlando; M S Lee; K Mizuuchi; M Krause; R Craigie
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

3.  Expanding small RNA interference.

Authors:  Thomas Tuschl
Journal:  Nat Biotechnol       Date:  2002-05       Impact factor: 54.908

4.  Asymmetric processing of human immunodeficiency virus type 1 cDNA in vivo: implications for functional end coupling during the chemical steps of DNA transposition.

Authors:  H Chen; A Engelman
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

5.  Role of the non-homologous DNA end joining pathway in the early steps of retroviral infection.

Authors:  L Li; J M Olvera; K E Yoder; R S Mitchell; S L Butler; M Lieber; S L Martin; F D Bushman
Journal:  EMBO J       Date:  2001-06-15       Impact factor: 11.598

6.  A previously unidentified host protein protects retroviral DNA from autointegration.

Authors:  M S Lee; R Craigie
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

7.  Regulatory mechanisms by which barrier-to-autointegration factor blocks autointegration and stimulates intermolecular integration of Moloney murine leukemia virus preintegration complexes.

Authors:  Youichi Suzuki; Robert Craigie
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

8.  Both the structure and DNA binding function of the barrier-to-autointegration factor contribute to reconstitution of HIV type 1 integration in vitro.

Authors:  D Harris; A Engelman
Journal:  J Biol Chem       Date:  2000-12-15       Impact factor: 5.157

9.  BAF is required for emerin assembly into the reforming nuclear envelope.

Authors:  T Haraguchi; T Koujin; M Segura-Totten; K K Lee; Y Matsuoka; Y Yoneda; K L Wilson; Y Hiraoka
Journal:  J Cell Sci       Date:  2001-12       Impact factor: 5.285

10.  Barrier-to-autointegration factor: major roles in chromatin decondensation and nuclear assembly.

Authors:  Miriam Segura-Totten; Amy K Kowalski; Robert Craigie; Katherine L Wilson
Journal:  J Cell Biol       Date:  2002-08-05       Impact factor: 10.539

View more
  69 in total

1.  Suppression of retroviral infection by the RAD52 DNA repair protein.

Authors:  Alan Lau; Roland Kanaar; Stephen P Jackson; Mark J O'Connor
Journal:  EMBO J       Date:  2004-08-05       Impact factor: 11.598

2.  Mechanisms and inhibition of HIV integration.

Authors:  Christophe Marchand; Allison A Johnson; Elena Semenova; Yves Pommier
Journal:  Drug Discov Today Dis Mech       Date:  2006-07-01

3.  Clinical Use of Inhibitors of HIV-1 Integration: Problems and Prospects.

Authors:  S P Korolev; Yu Yu Agapkina; M B Gottikh
Journal:  Acta Naturae       Date:  2011-07       Impact factor: 1.845

Review 4.  Emerging drug targets for antiretroviral therapy.

Authors:  Jacqueline D Reeves; Andrew J Piefer
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  Revealing domain structure through linker-scanning analysis of the murine leukemia virus (MuLV) RNase H and MuLV and human immunodeficiency virus type 1 integrase proteins.

Authors:  Jennifer Puglia; Tan Wang; Christine Smith-Snyder; Marie Cote; Michael Scher; Joelle N Pelletier; Sinu John; Colleen B Jonsson; Monica J Roth
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

6.  Barrier-to-autointegration factor phosphorylation on Ser-4 regulates emerin binding to lamin A in vitro and emerin localization in vivo.

Authors:  Luiza Bengtsson; Katherine L Wilson
Journal:  Mol Biol Cell       Date:  2005-12-21       Impact factor: 4.138

7.  Banf1 is required to maintain the self-renewal of both mouse and human embryonic stem cells.

Authors:  Jesse L Cox; Sunil K Mallanna; Briana D Ormsbee; Michelle Desler; Matthew S Wiebe; Angie Rizzino
Journal:  J Cell Sci       Date:  2011-07-12       Impact factor: 5.285

8.  In vivo biotinylation and capture of HIV-1 matrix and integrase proteins.

Authors:  Michael Belshan; Cameron J Schweitzer; Meghan R Donnellan; Richard Lu; Alan Engelman
Journal:  J Virol Methods       Date:  2009-03-26       Impact factor: 2.014

Review 9.  Integration site selection by retroviral vectors: molecular mechanism and clinical consequences.

Authors:  René Daniel; Johanna A Smith
Journal:  Hum Gene Ther       Date:  2008-06       Impact factor: 5.695

Review 10.  Chromatin tethering and retroviral integration: recent discoveries and parallels with DNA viruses.

Authors:  Anne M Meehan; Eric M Poeschla
Journal:  Biochim Biophys Acta       Date:  2009-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.